1-methyl-3-isobutylxanthine and ciprostene

1-methyl-3-isobutylxanthine has been researched along with ciprostene in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conanan, LB; Crutchley, DJ; Solomon, DE1
Hattori, R; Kawai, C; Shirotani, M; Yui, Y1

Other Studies

2 other study(ies) available for 1-methyl-3-isobutylxanthine and ciprostene

ArticleYear
Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Colforsin; Cyclic AMP; Endotoxins; Epoprostenol; Fluorescent Antibody Technique; Humans; Iloprost; Interleukin-1; Monocytes; Prostaglandins, Synthetic; Thromboplastin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1992
U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
    Prostaglandins, 1991, Volume: 41, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aorta; Cattle; Cell Division; Cells, Cultured; Cyclic AMP; DNA Replication; Endothelium, Vascular; Epoprostenol; Kinetics; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Prostaglandins, Synthetic; Thymidine; Tritium

1991